Quantcast

Second CA Glyphosate Trial Scheduled for Elderly Couple in Declining Health

Health + Wellness
Roundup for sale at a hardware store in San Rafael, CA, on July, 9. JOSH EDELSON / AFP / Getty Images

The first trial claiming long-term use of Monsanto's Roundup weedkiller caused the plaintiff's cancer ended with a $289 million jury verdict in favor of the plaintiff, though that was later reduced by a judge to $78 million.

Now, Monsanto's next date in the judgment seat in California has been set for March 18.


California Superior Court Judge Ioana Petrou granted an early trial Thursday to elderly couple Alva and Alberta Pilliod who claim their use of Roundup from 1975 to 2011 caused their non-Hodgkin lymphoma, Reuters reported.

Alva and Alberta used Roundup in their garden for decades before receiving their diagnoses in 2011 and 2015, respectively. Their case was one of around 250 similar claims that had not yet been assigned trial dates in Petrou's Oakland court, but they asked for an early trial due to declining health and fear of relapse, Courthouse News Service reported.

Alberta's lawyer Michael Miller testified that Alberta has two brain tumors and suffers from vertigo and nausea. She fell recently, had a large seizure that affected her balance and has to drive with one eye closed because of double vision.

"These are serious problems," Miller said during a Nov. 7 hearing, according to Courthouse News Service. "Let's get these folks a trial date."

The Pilliods' is one of around 9,300 pending U.S. cases claiming glyphosate, the active ingredient in Monsanto's Roundup weedkiller, caused the plaintiffs to develop cancer. Bayer, the German company that recently acquired Monsanto, claims that glyphosate is safe.

"While we have great sympathy for the plaintiffs, we are confident that our glyphosate-based herbicides were not the cause of their injuries and we will vigorously defend them at trial," the company said in a statement reported by Reuters.

The U.S. Environmental Protection Agency found glyphosate safe in 2017, but the World Health Organization's International Agency for Research on Cancer found that it was "probably carcinogenic to humans" in 2015.

Bayer has a lot riding on the outcomes of the pending trials. Its share price fell 30 percent since the first historic verdict was announced in August.

There are other glyphosate trials pending for next year, including one in St. Louis, Missouri. Federal cases bundled in a San Francisco case are scheduled to begin trial in late February.

Meanwhile, the plaintiff in the first trial, Dewayne Johnson, has continued his fight against Monsanto following his victory, which Bayer has said it will appeal.

Johnson spoke in Berkeley Wednesday night on the invitation of Herbicide-Free Cal, the group he is now working with.

"This is way bigger than I am. I'm just happy to be a part of it," Johnson said at the event, CBS Local SF BayArea reported. "Like I said, I'm the leaf that didn't die."

EcoWatch Daily Newsletter

Scanning electron micrograph of Yersinia pestis, which causes bubonic plague, on proventricular spines of a Xenopsylla cheopis flea. NIAID / Flickr / CC BY 2.0

A middle-aged married couple in China was diagnosed with pneumonic plague, a highly infectious disease similar to bubonic plague, which ravaged Europe in the middle ages, as CNN reported.

Read More Show Less
Milk made from almonds, oats and coconut are among the healthiest alternatives to cow's milk. triocean / iStock / Getty Images Plus

Dairy aisles have exploded with milk and milk alternative options over the past few years, and choosing the healthiest milk isn't just about the fat content.

Whether you're looking beyond cow's milk for health reasons or dietary preferences or simply want to experiment with different options, you may wonder which type of milk is healthiest for you.

Read More Show Less
Sponsored
Greta Thunberg stands aboard the catamaran La Vagabonde as she sets sail to Europe in Hampton, Virginia, on Nov. 13. NICHOLAS KAMM / AFP via Getty Images

Greta Thunberg, the teenage climate activist whose weekly school strikes have spurred global demonstrations, has cut short her tour of the Americas and set sail for Europe to attend COP25 in Madrid next month, as The New York Times reported.

Read More Show Less
The Lake Delhi Dam in Iowa failed in 2010. VCU Capital News Service / Josh deBerge / FEMA

At least 1,688 dams across the U.S. are in such a hazardous condition that, if they fail, could force life-threatening floods on nearby homes, businesses, infrastructure or entire communities, according to an in-depth analysis of public records conducted by the the Associated Press.

Read More Show Less

By Sabrina Kessler

Far-reaching allegations about how a climate-sinning American multinational could shamelessly lie to the public about its wrongdoing mobilized a small group of New York students on a cold November morning. They stood in front of New York's Supreme Court last week to follow the unprecedented lawsuit against ExxonMobil.

Read More Show Less
Sponsored

By Alex Robinson

Leah Garcés used to hate poultry farmers.

The animal rights activist, who opposes factory farming, had an adversarial relationship with chicken farmers until around five years ago, when she sat down to listen to one. She met a poultry farmer called Craig Watts in rural North Carolina and learned that the problems stemming from factory farming extended beyond animal cruelty.

Read More Show Less
People navigate snow-covered sidewalks in the Humboldt Park neighborhood on Nov. 11 in Chicago. Scott Olson / Getty Images

Temperatures plunged rapidly across the U.S. this week and around 70 percent of the population is expected to experience temperatures around freezing Wednesday.

Read More Show Less
A general view of the flooded St. Mark's Square after an exceptional overnight "Alta Acqua" high tide water level, on Nov. 13 in Venice. MARCO BERTORELLO / AFP / Getty Images

Two people have died as Venice has been inundated by the worst flooding it has seen in more than 50 years, The Guardian reported Wednesday.

Read More Show Less